HCi Viocare Announces Commencement of Financing Discussions
HCi Viocare today announced entering into discussions with various agents, private individuals and investment firms to raise additional capital for its 2016 and 2017 operations, as well as the expansion of its proposed chain of independent prosthetics and orthotics (P&O) and diabetic foot clinics.
Sotirios Leontaritis, CEO and President of HCi Viocare, stated: "The Company is in active discussions to raise new capital in order to accelerate the expansion of our prosthetics and orthotics (P&O) and diabetic foot clinics into new markets and for certain technology based project costs in relation to commercialization of various applications of our biomedical technologies in the current fiscal year. Our discussions extend to multiple formats for financing including both equity and debt financing, as well as joint venture discussions with third parties in relation to our branded clinics. We have recently engaged various agents who are actively assisting us in our fund-raising efforts."